Lv1
20 积分 2021-03-15 加入
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2–Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial
19天前
已完结
Factors that can make overall survival unreliable as a clinical trial outcome
27天前
已完结
Overall survival assessment in cancer drug trials: a luxury or a necessity?
27天前
已完结
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
28天前
已完结
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
28天前
已完结
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
29天前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
1个月前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
1个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2个月前
已完结
Natural cubic splines for the analysis of Alzheimer's clinical trials
2个月前
已完结
皖公网安备34019202002308
